PMID: 9661939Nov 20, 1998Paper

Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection

The Journal of Infection
Leena MattilaA Siitonen

Abstract

A large, single-source Salmonella outbreak caused by a rare serovar Bovismorbificans (6,8:r:1,5) occurred in southern Finland in 1994. The origin of the outbreak was sprouted alfalfa seeds. A questionnaire was mailed to all 210 subjects with positive stool culture. Ninety-one percent (191/210) returned the questionnaire. One hundred and fifty-three (80%) were adults. One hundred and fifty-nine out of one hundred and ninety-one (83%) reported diarrhoea, 109 (57%) fever, 104 (54%) abdominal pains, 83 (43%) fatigue, 66 (35%) articular symptoms and 20 (10%) had no symptoms. The median duration of diarrhoea was 5 days (range 1-35), that of other symptoms 4 days (range 1-30). Those reporting articular symptoms were examined (51 patients) or contacted by telephone (13 patients). Twelve percent (22/191) fulfilled the criteria for reactive arthritis (ReA). The difference in the incidence of ReA between children and adults was not significant (8%, vs. 12%). The median onset of joint symptoms was 8.5 days; symptoms were oligoarticular in 14 (67%) and polyarticular in four (19%) patients. Mostly ReA was mild, but in four patients (18%) the joint symptoms lasted for more than 4 months. Ten (45%) ReA patients had HLA-B27 tissue type. The dur...Continue Reading

References

Nov 1, 1989·Irish Journal of Medical Science·G B KondoweA J Taggart
Jun 1, 1985·Annals of the Rheumatic Diseases·V V ValtonenP H Mäkelä
Nov 1, 1971·Arthritis and Rheumatism·G N Lockie, G G Hunder
Oct 1, 1980·Annals of the Rheumatic Diseases·A C KeatJ T Scott
Aug 1, 1980·Arthritis and Rheumatism·F Y LeungC Bombardier
Feb 18, 1995·Lancet·A PönkäP Pakkala

❮ Previous
Next ❯

Citations

Jul 21, 2000·Arthritis and Rheumatism·P EkmanK Granfors
May 12, 2007·Applied Microbiology and Biotechnology·Xin-Wei WangJun-Wen Li
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M S DworkinJ M Kobayashi
Jul 26, 2000·Current Opinion in Rheumatology·R D InmanA P Hudson
Jun 24, 2003·Current Opinion in Rheumatology·Marjatta Leirisalo-RepoLeena Mattila
May 7, 2010·Current Opinion in Rheumatology·John D Carter, Alan P Hudson
Jul 9, 2011·Cornea·Nikolaos KozeisStraton Tyradellis
Jan 11, 2005·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Susanna LukinmaaAnja Siitonen
Apr 16, 2004·Clinical Microbiology Reviews·Inés ColmegnaLuis R Espinoza
Jun 25, 2002·Annals of the Rheumatic Diseases·J Sibilia, F-X Limbach
Aug 19, 2003·Annals of the Rheumatic Diseases·T HannuM Leirisalo-Repo
Aug 19, 2003·Annals of the Rheumatic Diseases·T Yli-KerttulaA Toivanen
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·M RudwaleitJ Sieper
Jul 6, 2014·International Journal of Inflammation·Animesh Singh, Sarah Karrar
Sep 21, 2001·Current Rheumatology Reports·Y LiuK Granfors
Nov 22, 2011·Best Practice & Research. Clinical Rheumatology·John D Carter, Robert D Inman
Nov 22, 2011·Best Practice & Research. Clinical Rheumatology·Timo Hannu
Jun 2, 2009·Rheumatic Diseases Clinics of North America·John D Carter, Alan P Hudson
Jul 1, 2007·Reumatología clinica·Francisco J QuirósUNKNOWN Miembros de las Unidades de Vigilancia Epidemiológica de Comunidades Autónomas
Sep 3, 2013·Journal of Travel Medicine·Bradley A Connor, Mark S Riddle
Nov 23, 2006·Infectious Disease Clinics of North America·John D Carter
Jan 16, 1999·Baillière's Clinical Rheumatology·P M Pelkonen
Jun 17, 2006·Best Practice & Research. Clinical Rheumatology·Timo HannuMarjatta Leirisalo-Repo
Jan 19, 1999·Rheumatic Diseases Clinics of North America·M Leirisalo-Repo
Dec 19, 2003·Expert Opinion on Pharmacotherapy·Carlo PalazziAttilio Petricca
Jul 22, 2004·Expert Opinion on Pharmacotherapy·Montserrat RuizGloria Royo
Oct 1, 2005·Scandinavian Journal of Rheumatology·M Leirisalo-Repo
Jan 15, 2013·Scandinavian Journal of Rheumatology·R TuompoM Leirisalo-Repo
Oct 20, 2015·Bulletin of the World Health Organization·Yuko KumagaiKenji Shibuya
Jan 20, 2006·FEMS Immunology and Medical Microbiology·Ian G Wilson, Esme Whitehead
Apr 6, 2002·Rheumatology·T HannuM Leirisalo-Repo
Jun 17, 2010·The Journal of Rheumatology·Alberto Arnedo-PenaFrancisco Guillen-Grima
Sep 18, 2017·Rheumatology International·Riitta TuompoMarjatta Leirisalo-Repo
Jul 20, 1999·Current Opinion in Rheumatology·J Sieper, J Braun
Jan 11, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Diederik BrandwagtEelco Franz
Oct 17, 2002·Rheumatic Diseases Clinics of North America·Rubén Burgos-Vargas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.